Henry Ward Wolff - Net Worth and Insider Trading

Henry Ward Wolff Net Worth

The estimated net worth of Henry Ward Wolff is at least $111,085 dollars as of 2024-05-11. Henry Ward Wolff is the Exec VP & CFO of Sangamo Therapeutics Inc and owns about 197,872 shares of Sangamo Therapeutics Inc (SGMO) stock worth over $111,085. Henry Ward Wolff is also the Director of Portola Pharmaceuticals Inc and owns about 0 shares of Portola Pharmaceuticals Inc (PTLA) stock worth over $0. Details can be seen in Henry Ward Wolff's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Henry Ward Wolff has not made any transactions after 2017-12-15 and currently still holds the listed stock(s).

Transaction Summary of Henry Ward Wolff

To

Henry Ward Wolff Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Henry Ward Wolff owns 6 companies in total, including Portola Pharmaceuticals Inc (PTLA) , Sunesis Pharmaceuticals Inc (SNSS) , and Calithera Biosciences Inc (CALA) among others .

Click here to see the complete history of Henry Ward Wolff’s form 4 insider trades.

Insider Ownership Summary of Henry Ward Wolff

Ticker Comapny Transaction Date Type of Owner
PTLA Portola Pharmaceuticals Inc 2020-07-02 director
SNSS Sunesis Pharmaceuticals Inc 2020-06-30 director
CALA Calithera Biosciences Inc 2016-06-14 director
2015-07-13 Exec VP & CFO
2006-07-24 Sr. VP Finance and CFO
2019-06-28 director

Henry Ward Wolff Latest Holdings Summary

Henry Ward Wolff currently owns a total of 2 stocks. Among these stocks, Henry Ward Wolff owns 197,872 shares of Sangamo Therapeutics Inc (SGMO) as of July 13, 2015, with a value of $111,085 and a weighting of 100%. Henry Ward Wolff also owns 0 shares of Portola Pharmaceuticals Inc (PTLA) as of December 15, 2017, with a value of $0 and a weighting of 0%.

Latest Holdings of Henry Ward Wolff

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGMO Sangamo Therapeutics Inc 2015-07-13 197,872 0.56 111,085
PTLA Portola Pharmaceuticals Inc 2017-12-15 0 18.03 0

Holding Weightings of Henry Ward Wolff


Henry Ward Wolff Form 4 Trading Tracker

According to the SEC Form 4 filings, Henry Ward Wolff has made a total of 0 transactions in Sangamo Therapeutics Inc (SGMO) over the past 5 years. The most-recent trade in Sangamo Therapeutics Inc is the sale of 12,000 shares on July 13, 2015, which brought Henry Ward Wolff around $120,000.

According to the SEC Form 4 filings, Henry Ward Wolff has made a total of 0 transactions in Portola Pharmaceuticals Inc (PTLA) over the past 5 years. The most-recent trade in Portola Pharmaceuticals Inc is the sale of 12,000 shares on December 15, 2017, which brought Henry Ward Wolff around $564,000.

Insider Trading History of Henry Ward Wolff

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Henry Ward Wolff Trading Performance

GuruFocus tracks the stock performance after each of Henry Ward Wolff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Henry Ward Wolff is 57.43%. GuruFocus also compares Henry Ward Wolff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Henry Ward Wolff within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Henry Ward Wolff's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Henry Ward Wolff

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.88
Relative Return to S&P 500(%) 7.08

Henry Ward Wolff Ownership Network

Ownership Network List of Henry Ward Wolff

No Data

Ownership Network Relation of Henry Ward Wolff


Henry Ward Wolff Owned Company Details

What does Portola Pharmaceuticals Inc do?

Who are the key executives at Portola Pharmaceuticals Inc?

Henry Ward Wolff is the director of Portola Pharmaceuticals Inc. Other key executives at Portola Pharmaceuticals Inc include EVP & General Counsel John B Moriarty , EVP and CFO Mardi Dier , and EVP & CMO Rajiv Patni .

Portola Pharmaceuticals Inc (PTLA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Portola Pharmaceuticals Inc Insider Transactions

No Available Data

Henry Ward Wolff Mailing Address

Above is the net worth, insider trading, and ownership report for Henry Ward Wolff. You might contact Henry Ward Wolff via mailing address: 6701 Kaiser Drive, Fremont Ca 94555.

Discussions on Henry Ward Wolff

No discussions yet.